Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 2004Cancer Research

BPR0L075, a Novel Synthetic Indole Compound with Antimitotic Activity in Human Cancer Cells, Exerts Effective Antitumoral Activityin Vivo

View Full Paper
Ask AI
Bookmark
Share

Authors

CKChing‐Chuan KuoTri-Service General HospitalHHHsing‐Pang HsiehNational Health Research InstitutesWPWen-Yu PanTaipei Medical University Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kuo et al. (2004) studied this question.

synapsesocial.com/papers/6a95dc6146cd8039cb92c7f8https://doi.org/10.1158/0008-5472.can-03-3474
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mitotic Phosphorylation of Bcl-2 during Normal Cell Cycle Progression and Taxol-induced Growth Arrest1998 · 230 citations
  2. 2BCL-2 Is Phosphorylated and Inactivated by an ASK1/Jun N-Terminal Protein Kinase Pathway Normally Activated at G<sub>2</sub>/M1999 · 1,006 citations
  3. 3Recent Progress in the Development of Tubulin Inhibitors As Antimitotic Antitumor Agents1970 · 105 citations
  4. 4Rapid Colchicine Competition-Binding Scintillation Proximity Assay Using Biotin-Labeled Tubulin2000 · 66 citations
  5. 5Caspases: the executioners of apoptosis1997 · 4,759 citations